3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Breast Neoplasms
1330
Neoplasms
984
Carcinoma, Non-Small-Cell Lung
860
Prostatic Neoplasms
728
Colorectal Neoplasms
665
Lung Neoplasms
551
Leukemia, Myeloid, Acute
476
Neoplasm Metastasis
435
Pancreatic Neoplasms
418
Carcinoma, Hepatocellular
408
Multiple Myeloma
396
Ovarian Neoplasms
391
Stomach Neoplasms
380
Recurrence
364
Squamous Cell Carcinoma of Head and Neck
324
Melanoma
294
Brain Neoplasms
289
Uterine Cervical Neoplasms
283
Triple Negative Breast Neoplasms
273
Glioblastoma
265
Head and Neck Neoplasms
264
Precursor Cell Lymphoblastic Leukemia-Lymphoma
255
Endometrial Neoplasms
233
Lymphoma
228
Rectal Neoplasms
223
Esophageal Neoplasms
222
Sarcoma
214
Carcinoma, Renal Cell
204
Colonic Neoplasms
194
Lymphoma, Non-Hodgkin
191
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Interventional
×
Fanconi Anemia, Complementation Group N
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled